• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于知识的片段结合预测。

Knowledge-based fragment binding prediction.

作者信息

Tang Grace W, Altman Russ B

机构信息

Department of Bioengineering, Stanford University, Stanford, California, United States of America.

Department of Bioengineering, Stanford University, Stanford, California, United States of America; Department of Genetics, Stanford University, Stanford, California, United States of America.

出版信息

PLoS Comput Biol. 2014 Apr 24;10(4):e1003589. doi: 10.1371/journal.pcbi.1003589. eCollection 2014 Apr.

DOI:10.1371/journal.pcbi.1003589
PMID:24762971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3998881/
Abstract

Target-based drug discovery must assess many drug-like compounds for potential activity. Focusing on low-molecular-weight compounds (fragments) can dramatically reduce the chemical search space. However, approaches for determining protein-fragment interactions have limitations. Experimental assays are time-consuming, expensive, and not always applicable. At the same time, computational approaches using physics-based methods have limited accuracy. With increasing high-resolution structural data for protein-ligand complexes, there is now an opportunity for data-driven approaches to fragment binding prediction. We present FragFEATURE, a machine learning approach to predict small molecule fragments preferred by a target protein structure. We first create a knowledge base of protein structural environments annotated with the small molecule substructures they bind. These substructures have low-molecular weight and serve as a proxy for fragments. FragFEATURE then compares the structural environments within a target protein to those in the knowledge base to retrieve statistically preferred fragments. It merges information across diverse ligands with shared substructures to generate predictions. Our results demonstrate FragFEATURE's ability to rediscover fragments corresponding to the ligand bound with 74% precision and 82% recall on average. For many protein targets, it identifies high scoring fragments that are substructures of known inhibitors. FragFEATURE thus predicts fragments that can serve as inputs to fragment-based drug design or serve as refinement criteria for creating target-specific compound libraries for experimental or computational screening.

摘要

基于靶点的药物发现必须评估许多具有潜在活性的类药物化合物。聚焦于低分子量化合物(片段)可以显著减少化学搜索空间。然而,确定蛋白质-片段相互作用的方法存在局限性。实验分析耗时、昂贵,且并非总是适用。同时,使用基于物理方法的计算方法准确性有限。随着蛋白质-配体复合物高分辨率结构数据的增加,现在有机会采用数据驱动的方法进行片段结合预测。我们提出了FragFEATURE,一种机器学习方法,用于预测目标蛋白质结构偏好的小分子片段。我们首先创建一个蛋白质结构环境知识库,用它们结合的小分子亚结构进行注释。这些亚结构分子量低,可作为片段的替代物。然后,FragFEATURE将目标蛋白质内的结构环境与知识库中的结构环境进行比较,以检索统计学上偏好的片段。它合并具有共享亚结构的不同配体的信息以生成预测。我们的结果表明,FragFEATURE能够重新发现与结合配体相对应的片段,平均精度为74%,召回率为82%。对于许多蛋白质靶点,它能识别出作为已知抑制剂亚结构的高分片段。因此,FragFEATURE预测的片段可作为基于片段的药物设计的输入,或作为创建用于实验或计算筛选的靶点特异性化合物库的优化标准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c6/3998881/537517339220/pcbi.1003589.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c6/3998881/553828e6bcb7/pcbi.1003589.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c6/3998881/5a93e5fb4c93/pcbi.1003589.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c6/3998881/c8ccea1e144f/pcbi.1003589.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c6/3998881/7d6defc84d35/pcbi.1003589.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c6/3998881/a3089afcedd7/pcbi.1003589.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c6/3998881/537517339220/pcbi.1003589.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c6/3998881/553828e6bcb7/pcbi.1003589.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c6/3998881/5a93e5fb4c93/pcbi.1003589.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c6/3998881/c8ccea1e144f/pcbi.1003589.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c6/3998881/7d6defc84d35/pcbi.1003589.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c6/3998881/a3089afcedd7/pcbi.1003589.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19c6/3998881/537517339220/pcbi.1003589.g006.jpg

相似文献

1
Knowledge-based fragment binding prediction.基于知识的片段结合预测。
PLoS Comput Biol. 2014 Apr 24;10(4):e1003589. doi: 10.1371/journal.pcbi.1003589. eCollection 2014 Apr.
2
In silico fragment-mapping method: a new tool for fragment-based/structure-based drug discovery.基于片段的/基于结构的药物发现的新工具:计算片段映射方法。
J Comput Aided Mol Des. 2018 Nov;32(11):1229-1245. doi: 10.1007/s10822-018-0160-8. Epub 2018 Sep 8.
3
Predicting target-ligand interactions using protein ligand-binding site and ligand substructures.利用蛋白质配体结合位点和配体亚结构预测靶标-配体相互作用。
BMC Syst Biol. 2015;9 Suppl 1(Suppl 1):S2. doi: 10.1186/1752-0509-9-S1-S2. Epub 2015 Jan 21.
4
Ligand specificity, privileged substructures and protein druggability from fragment-based screening.基于片段的筛选中的配体特异性、优势亚结构和蛋白质成药性。
Curr Opin Chem Biol. 2011 Aug;15(4):469-74. doi: 10.1016/j.cbpa.2011.02.020. Epub 2011 Mar 14.
5
Generalized modeling of enzyme-ligand interactions using proteochemometrics and local protein substructures.使用蛋白质化学计量学和局部蛋白质亚结构对酶-配体相互作用进行广义建模。
Proteins. 2006 Nov 15;65(3):568-79. doi: 10.1002/prot.21163.
6
The SeeDs approach: integrating fragments into drug discovery.种子法:将片段整合到药物发现中。
Curr Top Med Chem. 2007;7(16):1568-81. doi: 10.2174/156802607782341109.
7
Structure-guided fragment-based drug discovery at the synchrotron: screening binding sites and correlations with hotspot mapping.基于结构的基于片段的药物发现:在同步加速器上筛选结合部位,并与热点映射相关联。
Philos Trans A Math Phys Eng Sci. 2019 Jun 17;377(2147):20180422. doi: 10.1098/rsta.2018.0422.
8
Site Identification by Ligand Competitive Saturation (SILCS) simulations for fragment-based drug design.基于片段的药物设计中通过配体竞争饱和进行位点识别(SILCS)模拟
Methods Mol Biol. 2015;1289:75-87. doi: 10.1007/978-1-4939-2486-8_7.
9
Stalis: A Computational Method for Template-Based Ab Initio Ligand Design.Stalis:一种基于模板的从头算配体设计的计算方法。
J Comput Chem. 2019 Jun 30;40(17):1622-1632. doi: 10.1002/jcc.25813. Epub 2019 Mar 4.
10
Integrating Protein Interaction Surface Prediction with a Fragment-Based Drug Design: Automatic Design of New Leads with Fragments on Energy Surfaces.将蛋白质相互作用表面预测与基于片段的药物设计相结合:基于能量表面的片段自动设计新先导物。
J Chem Inf Model. 2023 Jan 9;63(1):343-353. doi: 10.1021/acs.jcim.2c01408. Epub 2022 Dec 27.

引用本文的文献

1
Unsupervised learning reveals landscape of local structural motifs across protein classes.无监督学习揭示了跨蛋白质类别的局部结构基序格局。
Bioinformatics. 2025 Jul 1;41(7). doi: 10.1093/bioinformatics/btaf377.
2
Predicting fragment binding modes using customized Lennard-Jones potentials in short molecular dynamics simulations.在短分子动力学模拟中使用定制的 Lennard-Jones 势预测片段结合模式。
Comput Struct Biotechnol J. 2024 Dec 23;27:102-116. doi: 10.1016/j.csbj.2024.12.017. eCollection 2025.
3
Streamlining Computational Fragment-Based Drug Discovery through Evolutionary Optimization Informed by Ligand-Based Virtual Prescreening.

本文引用的文献

1
Identifying druggable targets by protein microenvironments matching: application to transcription factors.通过蛋白质微环境匹配鉴定可成药靶标:在转录因子中的应用。
CPT Pharmacometrics Syst Pharmacol. 2014 Jan 22;3(1):e93. doi: 10.1038/psp.2013.66.
2
A comprehensive survey of small-molecule binding pockets in proteins.蛋白质中小分子结合口袋的综合调查。
PLoS Comput Biol. 2013 Oct;9(10):e1003302. doi: 10.1371/journal.pcbi.1003302. Epub 2013 Oct 24.
3
Interplay of physics and evolution in the likely origin of protein biochemical function.
通过基于配体的虚拟预筛选信息指导的进化优化,简化基于片段的药物发现的计算流程。
J Chem Inf Model. 2024 May 13;64(9):3826-3840. doi: 10.1021/acs.jcim.4c00234. Epub 2024 May 2.
4
COLLAPSE: A representation learning framework for identification and characterization of protein structural sites.崩溃:用于鉴定和描述蛋白质结构位点的表示学习框架。
Protein Sci. 2023 Feb;32(2):e4541. doi: 10.1002/pro.4541.
5
Defining A Global Map of Functional Group-based 3D Ligand-binding Motifs.定义基于功能基团的 3D 配体结合基序的全球图谱。
Genomics Proteomics Bioinformatics. 2022 Aug;20(4):765-779. doi: 10.1016/j.gpb.2021.08.014. Epub 2022 Mar 11.
6
CAVIAR: a method for automatic cavity detection, description and decomposition into subcavities.CAVIAR:一种自动检测、描述和分解腔隙的方法。
J Comput Aided Mol Des. 2021 Jun;35(6):737-750. doi: 10.1007/s10822-021-00390-w. Epub 2021 May 29.
7
A deep learning framework to predict binding preference of RNA constituents on protein surface.一种用于预测 RNA 成分与蛋白质表面结合偏好的深度学习框架。
Nat Commun. 2019 Oct 30;10(1):4941. doi: 10.1038/s41467-019-12920-0.
8
High precision protein functional site detection using 3D convolutional neural networks.利用 3D 卷积神经网络进行高精度蛋白质功能位点检测。
Bioinformatics. 2019 May 1;35(9):1503-1512. doi: 10.1093/bioinformatics/bty813.
9
Ranking Enzyme Structures in the PDB by Bound Ligand Similarity to Biological Substrates.根据与生物底物的结合配体相似性对 PDB 中的酶结构进行排名。
Structure. 2018 Apr 3;26(4):565-571.e3. doi: 10.1016/j.str.2018.02.009. Epub 2018 Mar 15.
10
Identification of Histamine H Receptor Ligands Using a New Crystal Structure Fragment-based Method.使用新的晶体结构片段为基础的方法鉴定组氨酸 H 受体配体。
Sci Rep. 2017 Jul 6;7(1):4829. doi: 10.1038/s41598-017-05058-w.
物理与进化在蛋白质生化功能起源中的相互作用。
Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9344-9. doi: 10.1073/pnas.1300011110. Epub 2013 May 20.
4
Adenosine-binding motif mimicry and cellular effects of a thieno[2,3-d]pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymes.基于噻吩并[2,3-d]嘧啶的新型蛋白激酶 C 同工型非典型化学抑制剂对腺苷结合基序模拟作用及细胞效应。
Biochem J. 2013 Apr 15;451(2):329-42. doi: 10.1042/BJ20121871.
5
Enumeration of 166 billion organic small molecules in the chemical universe database GDB-17.化学宇宙数据库 GDB-17 中 1660 亿个有机小分子的枚举。
J Chem Inf Model. 2012 Nov 26;52(11):2864-75. doi: 10.1021/ci300415d. Epub 2012 Nov 1.
6
ZINC: a free tool to discover chemistry for biology.ZINC:一款用于生物学的免费化学发现工具。
J Chem Inf Model. 2012 Jul 23;52(7):1757-68. doi: 10.1021/ci3001277. Epub 2012 Jun 15.
7
Substrate recognition mechanism of atypical protein kinase Cs revealed by the structure of PKCι in complex with a substrate peptide from Par-3.通过 PKCι 与 Par-3 来源的底物肽复合物的结构揭示非典型蛋白激酶 C 的底物识别机制。
Structure. 2012 May 9;20(5):791-801. doi: 10.1016/j.str.2012.02.022.
8
Experiences in fragment-based drug discovery.基于片段的药物发现的经验。
Trends Pharmacol Sci. 2012 May;33(5):224-32. doi: 10.1016/j.tips.2012.02.006. Epub 2012 Mar 27.
9
Diagnosing the decline in pharmaceutical R&D efficiency.诊断制药研发效率下降。
Nat Rev Drug Discov. 2012 Mar 1;11(3):191-200. doi: 10.1038/nrd3681.
10
Using multiple microenvironments to find similar ligand-binding sites: application to kinase inhibitor binding.利用多种微环境寻找相似的配体结合位点:在激酶抑制剂结合中的应用。
PLoS Comput Biol. 2011 Dec;7(12):e1002326. doi: 10.1371/journal.pcbi.1002326. Epub 2011 Dec 29.